ALK is a research-driven global pharmaceutical company focusing on allergy treatment, prevention and diagnosis. Our mission is to improve quality of life for allergic people by developing pharmaceutical products that target the actual cause of allergy. ALK is the world leader in allergy vaccination (immunotherapy) – a unique treatment that induces a protective immune response which reduces and potentially halts the allergic reaction. Allergy vaccination is traditionally administered as subcutaneous injections or sublingual droplets. Our aim is to extend the use of allergy vaccination by introducing convenient, tablet-based vaccines, thereby offering many more patients a causal allergy treatment. Following this strategy, the world’s first tablet-based vaccine against grass pollen allergy, GRAZAX®, was launched in Europe in 2007, and ALK has entered into a strategic partnership with Schering-Plough regarding the tablet programme in North America. ALK has approximately 1,500 employees with subsidiaries, production facilities and distributors worldwide. The company is headquartered in Hørsholm, Denmark and listed on NASDAQ OMX Copenhagen A/S. 'ALK' is an abbreviation of 'Allergological Laboratory Copenhagen (København)'. Further information is available at www.alk-abello.com and www.GRAZAX.com.
Specialties
Allergy treatment, Allergy vaccination, Allergy immunotherapy, Allergy emergency treatment, Allergy diagnostics
New hires at ALK Abelló
-
-
-
Research Scientist (3 month project position)
Came from...
GlaxoSmithKline, Scientific Advisor
-
-
ALK Abelló Activity on LinkedIn
-
ALK Abelló has a new Drug Safety Associate
Karina Phonekeo is now Drug Safety Associate, was Research Assistant at Faculty of Pharmaceutical Sciences, University of Copenhagen
-
ALK Abelló has a new Chemist, Analytical lead
Lotte Jensen is now Chemist, Analytical lead
-
ALK Abelló has a new Drug Safety Advisor
Malene Gottfredsen is now Drug Safety Advisor, was Safety Surveillance Advisor at Novo Nordisk A/S
-
ALK Abelló has a new Temporary Team Leader, QC Microbiology
Britt Schejbel is now Temporary Team Leader, QC Microbiology
-
ALK Abelló has a new Director Commercial Product Support
Rannvá Strøm is now Director Commercial Product Support
-
ALK Abelló has a new Research Scientist (3 month project position)
Charlotte Hejl is now Research Scientist (3 month project position), was Scientific Advisor at GlaxoSmithKline
